Bio-Reference Laboratories, Inc. (BRLI) reported first-quarter net income of $8.665 million or $0.31 per share. This is compared to net income of $7.365 million or $0.26 per share prior year.
Revenues were $161.26 million for the quarter. Revenues, as adjusted for Topic 954, were $138.79 million for the fourth-quarter of prior year.
On average, five analysts polled by Thomson Reuters expected the company to report profit per share of $0.28 for the quarter. Analysts' estimates typically exclude speical items. Analysts expected revenue of $165.44 million for the quarter.
The company re-affirmed its fiscal year 2013 guidance.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.